Insight into TPMT(∗)23 mutation mis-folding using molecular dynamics simulation and protein structure analysis

Journal of Biomolecular Structure & Dynamics
Sofiene LarifKamel Bouraoui

Abstract

Thiopurine S-methyltransferase (TPMT) is an important enzyme that metabolizes thiopurine drugs. This enzyme exhibits a large number of interindividual polymorphism. TPMT(∗)23 polymorphism has been reported in a few cases in the world in co-dominance with TPMT(∗)3A. The phenotype has been reported to affect enzyme activity in vivo and in vitro. Its underlying structural basis is not clarified yet. In our study, the wild type (WT) protein structure was analyzed and the amino acids bordering water channels in thiopurine sites were identified. Molecular dynamics of both the WT and TPMT(∗)23 mutation was carried out. In addition, the effects of this mutation, especially on the thiopurine site which is closed with a pincer like mechanism, were investigated. We focused on explaining how a locally occurred A167G substitution propagated through hydrogen bonds alteration to induce structural modification which affects both thiopurine and S-adenosylmethionine receptors. Finally, a genetic prediction of mutation functional consequences has been conducted confirming altered activity. An animated Interactive 3D Complement (I3DC) is available in Proteopedia at http://proteopedia.org/w/Journal:JBSD:20.

References

Sep 1, 1980·Clinical Pharmacology and Therapeutics·P A PazmiñoR M Weinshilboum
May 5, 2001·Genome Research·P C Ng, S Henikoff
Feb 22, 2002·Alimentary Pharmacology & Therapeutics·O DewitY Horsmans
Mar 5, 2002·Genome Research·Pauline C Ng, Steven Henikoff
May 23, 2002·Journal of the American Chemical Society·Kaihsu TaiJ Andrew McCammon
Aug 7, 2002·Current Opinion in Structural Biology·Roland L Dunbrack
Jun 26, 2003·Nucleic Acids Research·Pauline C Ng, Steven Henikoff
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·C Paul BarrettMartin E M Noble
Apr 28, 2005·Bioinformatics·C Paul Barrett, Martin E M Noble
Jul 11, 2006·Annual Review of Genomics and Human Genetics·Pauline C Ng, Steven Henikoff
Apr 4, 2007·Journal of Computational Chemistry·Carsten KutznerHelmut Grubmüller
Jun 8, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kersti Oselin, Kaili Anier
May 17, 2008·Journal of Molecular Biology·Karen Rutherford, Valerie Daggett
Aug 19, 2008·Pharmacogenetics and Genomics·Shuta UjiieMasahiro Hiratsuka
Mar 1, 2008·Journal of Chemical Theory and Computation·Berk HessErik Lindahl

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
PCA

Software Mentioned

rmsf
VMD viewer
Dynatraj
Linux
Gromacs
hbond
sas
UCSF Chimera
core2Quad
OpenMPI

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.